ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Diabetes Mellitus

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Diabetes Mellitus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Reinauer, H; Rösen, P	1

Other Studies

1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Diabetes Mellitus

Article	Year
Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats. Acta physiologica Hungarica, 1988, Volume: 71, Issue:2 Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Epoxy Compounds; Ethers, Cyclic; Glucose; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactates; Lipolysis; Male; Myocardium; Obesity; Pyruvates; Rats; Rats, Zucker	1988

Article

Year

Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.

Acta physiologica Hungarica, 1988, Volume: 71, Issue:2

Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Epoxy Compounds; Ethers, Cyclic; Glucose; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactates; Lipolysis; Male; Myocardium; Obesity; Pyruvates; Rats; Rats, Zucker

1988